![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/50 | |
A61K 31/554 | |||
A61K 31/785 | |||
A61K 9/16 | |||
A61K 45/06 | |||
A61P 1/00 | |||
A61P 1/16 | |||
A61P 3/00 | |||
A61P 43/00 | |||
A61P 1/12 | |||
A61P 3/06 |
(11) | Number of the document | 3413878 |
(13) | Kind of document | T |
(96) | European patent application number | 17705975.5 |
Date of filing the European patent application | 2017-02-09 | |
(97) | Date of publication of the European application | 2018-12-19 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/SE2017/050128 |
Date | 2017-02-09 |
(87) | Number | WO 2017/138878 |
Date | 2017-08-17 |
(30) | Number | Date | Country code |
1650157 | 2016-02-09 | SE |
(72) |
GILLBERG, Per-Göran, SE
GUSTAFSSON, Nils Ove, SE
LINDBERG, Nils-Olof, SE
ELVERSSON, Jessica, SE
|
(73) |
Albireo AB,
Arvid Wallgrens Backe 20, 413 46 Göteborg,
SE
|
(54) | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF |
ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF |